Literature DB >> 5330245

Effect of tolbutamide on postnatal neogenesis of the islet of Langerhans in mouse.

S C Bunnag, N E Warner, S Bunnag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5330245     DOI： 10.2337/diab.15.8.597

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  4 in total

1.  Beta cell nesidioblastosis.

Authors:  K Becker; U Wendel; H Przyrembel; M Tsotsalas; H Münterfering; H J Bremer
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

2.  [Experimental study on glibenclamide (HB 419), a new particularly active hypoglycaemic sulphonamide. II. Betacytotrophic action and stimulation of the neogenesis of the islets of Langerhans].

Authors:  A Loubatières; M M Mariani; R Alric; G Ribes; H de Malbosc; M H Houareau
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

3.  Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse.

Authors:  A J Williams; P E Beales; J Krug; E Procaccini; A Signore; S Xu; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

4.  Immunocytochemical localization of insulin-immunoreactive cells in the pancreatic ducts of rats treated with trypsin inhibitor.

Authors:  C V Weaver; R L Sorenson; H C Kaung
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.